Paul T. Edlefsen - Concepedia

Author

Paul T. Edlefsen

Also Known As

Andrew, Philip, Cohen, Myron S., Corey, Lawrence, Edlefsen, Paul, Edlefsen, Paul T., Matthew Clark, Paul T. Edlefsen, Paul Edlefsen, Paul T Edlefsen, Paul T. Edlefsen

105

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

Fred Hutch Cancer Center University of Washington Oregon National Primate Research Center Walter Reed Army Institute of Research Oregon Health & Science University

About

Paul T. Edlefsen is an author at Fred Hutch Cancer Center specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	2.2K
2	Public Health	2	2	55
3	Allergy	2	2	47
4	Biostatistics	2	2	55
5	Cell Biology	1	1	469

Paul T. Edlefsen

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection Thor A. Wagner, Sherry McLaughlin, Kavita S. Garg, Science	2014	689
Immune clearance of highly pathogenic SIV infection Scott G. Hansen, Michael Piatak, Abigail B. Ventura, Nature Viral PersistenceImmune ClearanceImmunologyAntiviral ResponseVirology	2013	611
B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers Yoshinori Fukazawa, Richard Lum, Afam A. Okoye, Nature Medicine Primary ImmunodeficiencyElite ControllersViral PersistenceHuman RetrovirusPathogenesis	2015	469
Cytomegalovirus Vectors Violate CD8 <sup>+</sup> T Cell Epitope Recognition Paradigms Scott G. Hansen, Jonah B. Sacha, Colette M. Hughes, Science	2013	430
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2 Morgane Rolland, Paul T. Edlefsen, Brendan B. Larsen, Nature VaccinationViral EvolutionGenetic SignaturesVaccine TargetHuman Retrovirus	2012	420
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies Allan C. deCamp, Peter Hraber, Robert T. Bailer, Journal of Virology	2013	340
Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines Yoshinori Fukazawa, Haesun Park, Mark J. Cameron, Nature Medicine VaccinationImmunologySiv VaccinesAutoimmunityCd4 T Cell Responses	2012	140
Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound Afam A. Okoye, Scott G. Hansen, Mukta Vaidya, Nature Medicine Viral PersistenceAntiviral Drug DevelopmentAntiviral TherapyVirologyAntiviral Drug	2018	121
Global profiling of <i>Shewanella oneidensis</i> MR-1: Expression of hypothetical genes and improved functional annotations Eugene Kolker, Alex F. Picone, Michael Y. Galperin, Proceedings of the National Academy of Sciences	2005	119
A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge Scott G. Hansen, Emily E. Marshall, Daniel Malouli, Science Translational Medicine	2019	110

Page 1